Blood Glucose Monitoring System | FCC ID WSX-IGM-1007A

By OSANG Healthcare Co., Ltd.

Last Updated: Jul 25, 2019 by FCC Insights

Add to favorites

Sign In or Register

Blood Glucose Monitoring System Device & FCC ID WSX-IGM-1007A Application Information


WSX-IGM-1007A was submitted on Jul 25, 2019 by OSANG Healthcare Co., Ltd. for a Blood Glucose Monitoring System.

In the table below, you will find the FCC ID information, application date, approved grant types, confidentiality agreement dates, the test facility used, and the TCB scope for ID WSX-IGM-1007A.
FCC IDWSX-IGM-1007AApplication PurposeOriginal Equipment
Application DateJul 25, 2019Brand Name
DescriptionBlood Glucose Monitoring SystemShort Term ConfidentialityNo
TCB ScopeA4: UNII devices & low power transmitters using spread spectrum techniquesLong Term ConfidentialityYes
Test FirmSK Tech Co., LTD.Short Term Confidentiality Released

Wireless Features


OSANG Healthcare Co., Ltd.'s Blood Glucose Monitoring System supports the following wireless features:

FeatureOperating FrequencySupported
Bluetooth2402 - 2480 MHz
Wi-Fi 42412 - 2462 MHz
Wi-Fi 55160 - 5885 MHz

Frequencies


Here is a closer look at FCC ID: WSX-IGM-1007A's supported operating frequencies and their approved power levels:

Frequency RangeEquipment ClassPower Level
2402 - 2480 MHzDTS - Digital Transmission System0.00069 W
Frequency Range in MegaHertzApproved Power Level in Watts
2402 - 24800.00069

Reports & Documents


Grants

No Grants found

Submitted Reports & Documents

Report Name

Report Type

Date Submitted

Date Available

Exhibit Type

No Documents Found


Learn More About OSANG Healthcare Co., Ltd.